HighTower Advisors
NAVB

HighTower Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-28,465
Closed -$48K 3249
2021
Q3
$48K Hold
28,465
﹤0.01% 2900
2021
Q2
$51K Buy
28,465
+13,000
+84% +$23.3K ﹤0.01% 2843
2021
Q1
$33K Sell
15,465
-20,600
-57% -$44K ﹤0.01% 2803
2020
Q4
$79K Buy
36,065
+4,450
+14% +$9.75K ﹤0.01% 2310
2020
Q3
$84K Buy
31,615
+4,075
+15% +$10.8K ﹤0.01% 2219
2020
Q2
$109K Buy
27,540
+12,450
+83% +$49.3K ﹤0.01% 2081
2020
Q1
$13K Hold
15,090
﹤0.01% 2041
2019
Q4
$18K Buy
15,090
+2,000
+15% +$2.39K ﹤0.01% 2124
2019
Q3
$11K Sell
13,090
-52
-0.4% -$44 ﹤0.01% 2252
2019
Q2
$5K Buy
+13,142
New +$5K ﹤0.01% 2246
2019
Q1
Sell
-46,440
Closed -$4K 2277
2018
Q4
$4K Sell
46,440
-35,116
-43% -$3.03K ﹤0.01% 2072
2018
Q3
$18K Hold
81,556
﹤0.01% 2126
2018
Q2
$18K Hold
81,556
﹤0.01% 2081
2018
Q1
$29K Sell
81,556
-63,410
-44% -$22.5K ﹤0.01% 2020
2017
Q4
$49K Sell
144,966
-20,000
-12% -$6.76K ﹤0.01% 2081
2017
Q3
$64K Sell
164,966
-13,000
-7% -$5.04K ﹤0.01% 2052
2017
Q2
$93K Hold
177,966
﹤0.01% 1967
2017
Q1
$104K Buy
177,966
+11,900
+7% +$6.95K ﹤0.01% 1860
2016
Q4
$107K Buy
166,066
+4,800
+3% +$3.09K ﹤0.01% 1765
2016
Q3
$146K Buy
161,266
+1,800
+1% +$1.63K ﹤0.01% 1689
2016
Q2
$84K Buy
159,466
+18,200
+13% +$9.59K ﹤0.01% 1603
2016
Q1
$131K Buy
141,266
+5,000
+4% +$4.64K ﹤0.01% 1806
2015
Q4
$178K Sell
136,266
-8,490
-6% -$11.1K ﹤0.01% 1773
2015
Q3
$333K Sell
144,756
-322,382
-69% -$742K ﹤0.01% 1404
2015
Q2
$752K Buy
467,138
+444,738
+1,985% +$716K 0.01% 868
2015
Q1
$36K Buy
22,400
+5,500
+33% +$8.84K ﹤0.01% 1558
2014
Q4
$32K Buy
+16,900
New +$32K ﹤0.01% 1532